Iteos Therapeutics Inc
NASDAQ:ITOS

Watchlist Manager
Iteos Therapeutics Inc Logo
Iteos Therapeutics Inc
NASDAQ:ITOS
Watchlist
Price: 10.15 USD Market Closed
Market Cap: 448.7m USD

Intrinsic Value

The intrinsic value of one ITOS stock under the Base Case scenario is 0.46 USD. Compared to the current market price of 10.15 USD, Iteos Therapeutics Inc is Overvalued by 95%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ITOS Intrinsic Value
0.46 USD
Overvaluation 95%
Intrinsic Value
Price
Base Case Scenario

Valuation History
Iteos Therapeutics Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about ITOS?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is ITOS valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Iteos Therapeutics Inc.

Explain Valuation
Compare ITOS to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ITOS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Iteos Therapeutics Inc

Current Assets 529m
Cash & Short-Term Investments 515.4m
Receivables 2.5m
Other Current Assets 11m
Non-Current Assets 94.1m
Long-Term Investments 74.6m
PP&E 10.3m
Other Non-Current Assets 9.2m
Current Liabilities 70.3m
Accounts Payable 6.2m
Accrued Liabilities 62.5m
Other Current Liabilities 1.5m
Non-Current Liabilities 59m
Other Non-Current Liabilities 59m
Efficiency

Free Cash Flow Analysis
Iteos Therapeutics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Iteos Therapeutics Inc

Revenue
0 USD
Operating Expenses
-165.6m USD
Operating Income
-165.6m USD
Other Expenses
-2.2m USD
Net Income
-167.8m USD
Fundamental Scores

ITOS Profitability Score
Profitability Due Diligence

Iteos Therapeutics Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Low 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
38/100
Profitability
Score

Iteos Therapeutics Inc's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

ITOS Solvency Score
Solvency Due Diligence

Iteos Therapeutics Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
64/100
Solvency
Score

Iteos Therapeutics Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ITOS Price Targets Summary
Iteos Therapeutics Inc

There are no price targets for ITOS.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Iteos Therapeutics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for ITOS is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ITOS Insider Trading
Buy and sell transactions by insiders

ITOS News

What is the Intrinsic Value of one ITOS stock?

The intrinsic value of one ITOS stock under the Base Case scenario is 0.46 USD.

Is ITOS stock undervalued or overvalued?

Compared to the current market price of 10.15 USD, Iteos Therapeutics Inc is Overvalued by 95%.

Back to Top